about
Africa's 32 cents solution for HIV/AIDSHuman Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionAlcohol and HIV Effects on the Immune SystemOral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesThe Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsDisparities and risks of sexually transmissible infections among men who have sex with men in China: a meta-analysis and data synthesis.Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy.A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 1997-2006.In vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge modelAcyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.How can we design better vaccines to prevent HIV infection in women?Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histoculturesThe epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto.Adolescent girls and young women: key populations for HIV epidemic controlSubstance use and the development of sexual risk behaviors in youth perinatally exposed to HIV.Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis among men who have sex with men in Brazil.The use of preexposure treatments for HIV prophylaxisSTI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use.Qualitative evaluation of a Positive Prevention training for health care providers in Mozambique.Co-infection with human immunodeficiency virus and tuberculosis in AsiaAnal human papillomavirus infection is associated with HIV acquisition in men who have sex with men.Does ART prevent HIV transmission among MSM?Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.Sexual Health Knowledge in a Sample of Perinatally HIV-infected and Perinatally-exposed Uninfected YouthThe "3 in 1" Study: Pooling Self-Taken Pharyngeal, Urethral, and Rectal Samples into a Single Sample for Analysis for Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex with Men.The future of HIV prevention: control of sexually transmitted infections and circumcision interventionsTNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivoNeisseria gonorrhoeae-derived heptose elicits an innate immune response and drives HIV-1 expressionA new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York.Recent multiple sexual partners and HIV transmission risks among people living with HIV/AIDS in BotswanaSexually transmitted infections among patients with acute HIV in North CarolinaThe frequency of α₄β₇(high) memory CD4⁺ T cells correlates with susceptibility to rectal simian immunodeficiency virus infection.Predictors of unprotected sex among men who have sex with men in Beijing, China.gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue.Biomedical approaches to HIV preventionReduction in STIs in an empowerment intervention programme for female sex workers in Bangalore, India: the Pragati programme.Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug usersM48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.
P2860
Q21092298-AF043A0C-3209-437F-A44E-F781CAC42600Q26751304-C277B8DB-180F-45AF-A284-45B7721D7F34Q26773216-30033ED6-FE1D-4EE0-95F3-DCA21D13B31DQ27023352-7DC456F2-A4F7-403A-B76C-0284072993C7Q28302792-5262FE8E-834B-42CE-AD24-C106220B2C97Q30768795-10781D48-015F-4EE4-A354-F341422500D6Q33405725-EF42AD4B-3289-414B-97EC-5752BA630A38Q33609662-89563A49-C6B1-47AF-8EF2-3182F5973915Q34118214-620450A5-0EEC-4F75-A1FB-F9ED9CA59CCAQ34387113-56817380-4DC7-4E8B-9529-C510C054108DQ34408370-3C9185AC-1566-4A66-AAC9-1D2F402802E0Q34449068-4E14A801-866E-4A0C-B86A-5D1AD0C36DCFQ35014689-30BD7243-B84F-431E-AEFD-9D4E4D608A1AQ35044610-ACA9EC83-9408-4F60-9119-D9AC95F34877Q35131236-6571154C-57B7-4B17-819E-77EDE6D10BC7Q35510706-206789DF-954D-460A-9E0B-2937580F7C29Q35701315-0F09DCF4-F8E3-4AE0-8E60-A767C9D67003Q35760180-39EDE984-0EC8-4BC4-9267-056831E3B461Q35920588-42D58410-786B-40F5-A2B6-B9574E403F0CQ36002873-51AF9357-F725-45D0-B2FB-DC8528CFE1AEQ36074442-0927C9F5-8E8F-42B6-AB25-9F8B9C14B951Q36079480-94780CDF-C2D2-45A2-BD71-E4677EA4CD1CQ36403679-0FBF2427-7405-4AD2-B410-6752C5EA3A8FQ36482710-01507881-7B84-4779-AACC-A03F75182B50Q36551988-572D62F7-1342-46C4-9A25-FD47E0FF8C2DQ36620848-18EA0730-39EE-4ACC-B273-5E101A604A38Q36821667-0C2A3BAB-0867-46C8-A1D2-6255118CAFDEQ36861237-45D374A2-683A-490D-887C-B99A84935B86Q36950468-0C674FE7-4185-4FFD-8B97-C37081917510Q37108089-A6A8FDA6-EE93-4BA4-873E-D7D68BEEED90Q37125560-C45B2343-2379-4B75-A516-606733512E7FQ37136335-4B6C7D36-F401-4D10-8046-113C6018CE58Q37255469-3B4FDD85-40FC-4085-B0EA-8BB8FCE16F8FQ37273768-87CC20EF-2D20-4707-AB82-ADF773058557Q37315428-36107232-3182-4B9E-973D-D903E38C763CQ37333741-9BA9F64B-FA79-48BC-8209-C59388A810EFQ37386665-C5898FEF-0D99-4B49-BAE3-3293F88AEEDAQ37419577-A502F321-F359-4DE0-A86D-57B11840F8E5Q37582263-B789BC96-CDE0-4F83-BE2F-8FA88EE700B8Q37618276-1BC3FE99-AB8E-4282-B115-8811EB0BEDE5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
HIV and sexually transmitted diseases: lethal synergy.
@ast
HIV and sexually transmitted diseases: lethal synergy.
@en
type
label
HIV and sexually transmitted diseases: lethal synergy.
@ast
HIV and sexually transmitted diseases: lethal synergy.
@en
prefLabel
HIV and sexually transmitted diseases: lethal synergy.
@ast
HIV and sexually transmitted diseases: lethal synergy.
@en
P921
P1476
HIV and sexually transmitted diseases: lethal synergy.
@en
P304
P577
2004-10-01T00:00:00Z